NCT06941753 Off-script Diagnosis & Differential Diagnosis (D&D) Training and Residents' Stroke Knowledge
| NCT ID | NCT06941753 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking Union Medical College Hospital |
| Condition | Stroke, Acute |
| Study Type | INTERVENTIONAL |
| Enrollment | 22 participants |
| Start Date | 2025-06-20 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 22 participants in total. It began in 2025-06-20 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a single-center, randomized, open-label, controlled, endpoint-blinded study to assess the effect of off-script diagnosis \& differential diagnosis (D\&D) training in improving the residents' knowledge of acute ischemic stroke in China. The investigators will enroll 22 residents and assess the score of mASMaQ 30 days after randomization.
Eligibility Criteria
Inclusion Criteria: 1. Residents (physicians in postgraduate training). 2. Currently in neurology wards 3. Managing acute ischemic stroke (AIS) patients, defined as: 1)Time from onset to randomization ≤ 2 weeks; 2) If onset time is unknown, the last known well time is considered the onset time. 4. Signed informed consent Exclusion Criteria: 1. Managing asymptomatic ischemic stroke patients. 2. Residents who are currently participating or have participated in another interventional ischemic stroke training program within the past 3 months.
Contact & Investigator
Jun Ni, MD
PRINCIPAL INVESTIGATOR
Peking Union Medical College Hospital
Frequently Asked Questions
Who can join the NCT06941753 clinical trial?
This trial is open to participants of all sexes, studying Stroke, Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06941753 currently recruiting?
Yes, NCT06941753 is actively recruiting participants. Contact the research team at lishengde.medicine@qq.com for enrollment information.
Where is the NCT06941753 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06941753 clinical trial?
NCT06941753 is sponsored by Peking Union Medical College Hospital. The principal investigator is Jun Ni, MD at Peking Union Medical College Hospital. The trial plans to enroll 22 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.